Samer Gamil is a seasoned professional with over 20 years of experience in the pharmaceutical and biopharmaceutical sectors, currently serving as the International Value & Access Alzheimer Diseases & Diagnostics Associate Director at Eli Lilly. Having held various managerial positions within Eli Lilly for the past 15 years, Samer has developed expertise in strategy, execution, and people management, focusing on optimizing ROI and enhancing stakeholder satisfaction. Samer’s roles have included leadership in pricing, reimbursement, and market access strategies, along with a strong commitment to team development and mentorship. They have received exemplary performance ratings throughout their career, demonstrating a consistent ability to turn strategies into actionable plans. Samer earned a Bachelor's degree in Pharmaceuticals and has pursued further education in market access and health economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices